Annals of the New York Academy of Sciences

Cover image for Annals of the New York Academy of Sciences

July 1985

Volume 448 Neuronal Cholecystokinin

Pages xiii–xiii, 1–686

    1. Preface (page xiii)

      JEAN-JACQUES VANDERHAEGHEN and JACQUELINE N. CRAWLEY

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29899.x

  1. Part I. Neurochemistry

    1. Top of page
    2. Part I. Neurochemistry
    3. Part II. Synthesis and Metabolism
    4. Part III. Neuroanatomy
    5. Part IV. Receptors
    6. Part V. Co-existence
    7. Part VI. Neurophysiology
    8. Part VII. Behavior
    9. Part VIII. Clinical Significance
    10. Poster Papers
    1. Molecular Forms of Cholecystokinin in the Nervous System (pages 9–10)

      MICHAEL J. BROWNSTEIN and JENS F. REHFELD

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29901.x

    2. Molecular Forms of Cholecystokinin in the Brain and the Relationship to Neuronal Gastrins (pages 11–23)

      J. F. REHFELD, H. F. HANSEN, P. D. MARLEY and K. STENGAARD-PEDERSEN

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29902.x

    3. Studies on Brain Cholecystokinin in Different Species Using Sequencespecific Antisera (pages 24–31)

      J.B.M.J. JANSEN and C.B.H.W. LAMERS

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29903.x

    4. Cholecystokinin and Gastrin Forms in the Nervous System (pages 32–43)

      G. J. DOCKRAY, H. DESMOND, R. J. GAYTON, A-C. JONSSON, H. RAYBOULD, K. A. SHARKEY, A. VARRO and R. G. WILLIAMS

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29904.x

    5. Neurochemistry of Cholecystokinin in Brain, Pituitary, and Cerebrospinal Fluid (pages 44–52)

      MARGERY C. BEINFELD and ANITA CIARLEGLIO

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29905.x

  2. Part II. Synthesis and Metabolism

    1. Top of page
    2. Part I. Neurochemistry
    3. Part II. Synthesis and Metabolism
    4. Part III. Neuroanatomy
    5. Part IV. Receptors
    6. Part V. Co-existence
    7. Part VI. Neurophysiology
    8. Part VII. Behavior
    9. Part VIII. Clinical Significance
    10. Poster Papers
    1. Modulation of Cholecystokinin Gene Expression (pages 53–60)

      ROBERT J. DESCHENES, RANDY S. HAUN, DAN SUNKEL, BERNARD A. ROOS and JACK E. DIXON

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29906.x

    2. Studies on the Conformation, Enzymatic Degradation, Pharmacological Potency, and Binding Properties in Brain Tissue of Cholecystokinin-8 and New Related Peptides (pages 61–75)

      B. P. ROQUES, C. DURIEUX, G. GACEL, D. PÉLAPRAT, M. RUIZ-GAYO, J. BELLENEY, E. FELLION, J. M. ZAJAC, M-C. FOURNIÉ-ZALUSKI, V. DAUGÉ, I. MENANT, P. ROSSIGNOL, B. LUX, D. GÉRARD, D. BÉCUÉ, A. SASAKI and J. L. MORGAT

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29907.x

    3. The Biosynthesis of Cholecystokinin in Neural Tissue (pages 76–86)

      NILS R. GOLTERMANN

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29908.x

    4. Enzymatic Degradation of Cholecystokinin in the Central Nervous System (pages 87–98)

      MONIQUE DESCHODT-LANCKMAN

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29909.x

    5. Cholecystokinin in Intracerebral Transplants (pages 99–109)

      M. SCHULTZBERG

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29910.x

    6. Sulfation and Desulfation of Cerebral Cholecystokinin (pages 110–120)

      FROYLAN VARGAS, OLIVIER FREROT, MI DAM TRUNG TUONG, KATHERINE ZUZEL, CHRISTIANE ROSE and JEAN-CHARLES SCHWARTZ

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29911.x

  3. Part III. Neuroanatomy

    1. Top of page
    2. Part I. Neurochemistry
    3. Part II. Synthesis and Metabolism
    4. Part III. Neuroanatomy
    5. Part IV. Receptors
    6. Part V. Co-existence
    7. Part VI. Neurophysiology
    8. Part VII. Behavior
    9. Part VIII. Clinical Significance
    10. Poster Papers
    1. The Distribution and Some Connections of Cholecystokinin Neurons in the Rat Brain (pages 121–132)

      JAMES H. FALLON and KIM B. SEROOGY

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29912.x

    2. Cholecystokinin in the Retina of Vertebrates (pages 157–166)

      NEVILLE N. OSBORNE

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29916.x

    3. Cholecystokinin in the Nervous Systems of Invertebrates and Protochordates : Immunohistochemical Localization of a Cholecystokinin-8-like Substance in Annelids and Insects (pages 167–187)

      N. DHAINAUT-COURTOIS, G. TRAMU, R. MARCEL, J. MALÉCHA, M. VERGER-BOCQUET, J. C. ANDRIÈS, M. MASSON, L. SELLOUM, G. BELEMTOUGRI and J. C. BEAUVILLAIN

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29917.x

  4. Part IV. Receptors

    1. Top of page
    2. Part I. Neurochemistry
    3. Part II. Synthesis and Metabolism
    4. Part III. Neuroanatomy
    5. Part IV. Receptors
    6. Part V. Co-existence
    7. Part VI. Neurophysiology
    8. Part VII. Behavior
    9. Part VIII. Clinical Significance
    10. Poster Papers
    1. Integrated Anatomical and Physiological Studies of Neuronal Cholecystokinin Receptors (pages 188–197)

      ROBERT B. INNIS and GEORGE K. AGHAJANIAN

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29918.x

    2. Brain Cholecystokinin Receptors : Binding Characteristics, Covalent Cross-linking, and Evolutionary Aspects (pages 220–230)

      JOHN A. WILLIAMS, STEVEN R. VIGNA, CHOITSU SAKAMOTO and IRA D. GOLDFINE

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29920.x

    3. Cholecystokinin Neuron Systems and Their Interactions with the Presynaptic Features of the Dopamine Neuron Systems : A Morphometric and Neurochemical Analysis Involving Studies on the Action of Cholecystokinin-8 and Cholecystokinin-58 (pages 231–254)

      K. FUXE, L. F. AGNATI, J-J. VANDERHAEGHEN, K. TATEMOTO, K. ANDERSSON, P. ENEROTH, A. HÄRFSTRAND, G. VON EULER, R. TONI, M. GOLDSTEIN and V. MUTT

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29921.x

  5. Part V. Co-existence

    1. Top of page
    2. Part I. Neurochemistry
    3. Part II. Synthesis and Metabolism
    4. Part III. Neuroanatomy
    5. Part IV. Receptors
    6. Part V. Co-existence
    7. Part VI. Neurophysiology
    8. Part VII. Behavior
    9. Part VIII. Clinical Significance
    10. Poster Papers
    1. Distribution of Cholecystokinin-like Immunoreactivity in the Nervous System : Co-existence with Classical Neurotransmitters and Other Neuropeptides (pages 255–274)

      T. HÖKFELT, L. SKIRBOLL, B. EVERITT, B. MEISTER, M. BROWNSTEIN, T. JACOBS, A. FADEN, S. KUGA, M. GOLDSTEIN, R. MARKSTEIN, G. DOCKRAY and J. REHFELD

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29922.x

    2. In Vivo Sulfation of Cholecystokinin Octapeptide : Possible Interactions of the Two Forms of Cholecystokinin with Dopamine in the Brain (pages 293–305)

      B. PENKE, G. L. KOVÁCS, J. ZSIGÓ, T. KÁDÁR, G. SZABÓ, K. KOVÁCS and G. TELEGDY

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29925.x

    3. Distinct Properties of Cholecystokinin-8 and Mixed Dopamine-Cholecystokinin-8 Neurons Innervating the Nucleus Accumbens (pages 306–314)

      J. M. STUDLER, M. REIBAUD, G. TRAMU, G. BLANC, J. GLOWINSKI and J. P. TASSIN

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29926.x

    4. Evidence for Cholecystokinin-Dopamine Receptor Interactions in the Central Nervous System of the Adult and Old Rat : Studies on Their Functional Meaning (pages 315–333)

      L. F. AGNATI, K. FUXE, L. GIARDINO, L. CALZA, M. ZOLI, N. BATTISTINI, F. BENFENATI, J-J. VANDERHAEGHEN, D. GUIDOLIN, M. RUGGERI and M. GOLDSTEIN

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29927.x

    5. Co-existence of Cholecystokinin- or Gastrin-like Peptides with Other Peptides in the Hypophysis and the Hypothalamus (pages 334–344)

      J-J. VANDERHAEGHEN, S. GOLDMAN, F. LOTSTRA, O. VAN REETH, C. DESCHEPPER, J. ROSSIER and S. SCHIFFMANN

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29928.x

  6. Part VI. Neurophysiology

    1. Top of page
    2. Part I. Neurochemistry
    3. Part II. Synthesis and Metabolism
    4. Part III. Neuroanatomy
    5. Part IV. Receptors
    6. Part V. Co-existence
    7. Part VI. Neurophysiology
    8. Part VII. Behavior
    9. Part VIII. Clinical Significance
    10. Poster Papers
    1. Interactions of Cholecystokinin and Dopamine in the Nucleus Accumbens (pages 352–360)

      REX Y. WANG, FRANCIS J. WHITE and MARK M. VOIGT

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29930.x

    2. Cholecystokinin as a Potent Excitant of Neurons of the Dentate Gyrus of Rats (pages 361–374)

      PENNY A. BROOKS and JOHN S. KELLY

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29931.x

    3. The Effects of Cholecystokinin-8 in the Nucleus Tractus Solitarius (pages 375–384)

      M. DENAVIT-SAUBIÉ, M. A. HURLÉ, M. P. MORIN-SURUN, A. S. FOUTZ and J. CHAMPAGNAT

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29932.x

    4. Actions of Cholecystokinin Octapeptide on Rat Spinal Dorsal Horn Neurons (pages 385–402)

      J. WILLETTS, L. URBAN, K. MURASE and M. RANDIĆ

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29933.x

    5. Cholecystokinin and Cultured Spinal Neurons Immunohistochemistry, Receptor Binding, and Neurophysiology (pages 403–412)

      M. A. ROGAWSKI, M. C. BEINFELD, S. E. HAYS, T. HÖKFELT and L. R. SKIRBOLL

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29934.x

  7. Part VII. Behavior

    1. Top of page
    2. Part I. Neurochemistry
    3. Part II. Synthesis and Metabolism
    4. Part III. Neuroanatomy
    5. Part IV. Receptors
    6. Part V. Co-existence
    7. Part VI. Neurophysiology
    8. Part VII. Behavior
    9. Part VIII. Clinical Significance
    10. Poster Papers
    1. Species Differences in the Response to Cholecystokinin (pages 413–416)

      JOHN E. MORLEY, ALLEN S. LEVINE, TIMOTHY J. BARTNESS, STEVEN E. NIZIELSKI, MICHAEL J. SHAW and JOHN J. HUGHES

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29935.x

    2. The Satiety Effect of Cholecystokinin Recent Progress and Current Problems (pages 417–423)

      G. P. SMITH and J. GIBBS

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29936.x

    3. Central Nervous System Cholecystokinin and the Control of Feeding (pages 424–430)

      CLIFTON A. BAILE and MARY ANNE DELLA-FERA

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29937.x

    4. Psychopharmacological Profile of Cholecystokinin Using the Self-Stimulation and the Drug Discrimination Paradigms (pages 470–487)

      P. DE WITTE, E. SWANET, M. GEWISS, S. GOLDMAN, B. ROQUES and J-J. VANDERHAEGHEN

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29941.x

  8. Part VIII. Clinical Significance

    1. Top of page
    2. Part I. Neurochemistry
    3. Part II. Synthesis and Metabolism
    4. Part III. Neuroanatomy
    5. Part IV. Receptors
    6. Part V. Co-existence
    7. Part VI. Neurophysiology
    8. Part VII. Behavior
    9. Part VIII. Clinical Significance
    10. Poster Papers
    1. Reduced Cholecystokinin Levels in the Limbic Lobe in Schizophrenia : A Marker for Pathology Underlying the Defect State? (pages 495–506)

      I. N. FERRIER, T. J. CROW, S. M. FARMERY, G. W. ROBERTS, F. OWEN, T. E. ADRIAN and S. R. BLOOM

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29943.x

    2. Reduced Cholecystokinin Levels in Cerebrospinal Fluid of Parkinsonian and Schizophrenic Patients Effect of Ceruletide in Schizophrenia (pages 507–517)

      F. LOTSTRA, P. M. P. VERBANCK, C. GILLES, J. MENDLEWICZ and J-J. VANDERHAEGHEN

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29944.x

    3. Clinical and Neuroendocrine Studies with Cholecystokinin Peptides (pages 535–541)

      N. P. V. NAIR, D. BLOOM, S. LAL, G. DEBONNEL, G. SCHWARTZ and S. MOSTICYAN

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29946.x

    4. The Effects of Cholecystokinin-like Peptides in Schizophrenics and Normal Human Subjects (pages 542–552)

      DANIEL W. HOMMER, DAVID PICKAR, JACQUELINE N. CRAWLEY, HERBERT WEINGARTNER and STEVEN M. PAUL

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29947.x

    5. Cholecystokinin-mediated Synaptic Function and the Treatment of Neuropsychiatric Disease (pages 553–561)

      T. N. CHASE, P. BARONE, G. BRUNO, S. L. COHEN, J. JUNCOS, M. KNIGHT, S. RUGGERI, L. STEARDO and C. A. TAMMINGA

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29948.x

  9. Poster Papers

    1. Top of page
    2. Part I. Neurochemistry
    3. Part II. Synthesis and Metabolism
    4. Part III. Neuroanatomy
    5. Part IV. Receptors
    6. Part V. Co-existence
    7. Part VI. Neurophysiology
    8. Part VII. Behavior
    9. Part VIII. Clinical Significance
    10. Poster Papers
    1. A New Specific Assay for Cholecystokinin Octapeptide (pages 566–567)

      T. E. ADRIAN, A. J. BACARESE-HAMILTON and S. R. BLOOM

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29950.x

    2. Cholecystokinin-like Immunoreactivity in the Rat Nucleus Accumbens : An Ultrastructural Study (pages 568–570)

      H. BAALI-CHERIF, M. ARLUISON and G. TRAMU

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29951.x

    3. Prevention of Cholecystokinin Oxidation During Tissue Extraction : A Major Problem Solved (pages 571–572)

      A. J. BACARESE-HAMILTON, T. E. ADRIAN and S. R. BLOOM

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29952.x

    4. Antagonism of Cholecystokinin by Naloxone and Proglumide in Mice (pages 573–574)

      B. S. BARBAZ, W. L. AUTRY, F. G. AMBROSE, R. GERBER and J. M. LIEBMAN

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29953.x

    5. Cholecystokinin-like Immunoreactivity in the Dorsal Horn of the Rat Spinal Cord (pages 583–585)

      M. CONRATH-VERRIER, M. DIETL and G. TRAMU

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29956.x

    6. Distribution of Cholecystokinin-containing Neurons in Cat Visual Cortex (pages 589–592)

      H. DEMEULEMEESTER, F. VANDESANDE and G. A. ORBAN

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29958.x

    7. Degradation Processes and Binding Properties of Cholecystokinin and Related Compounds : Studies Using a New Tritiated Ligand (pages 593–595)

      CHRISTIANE DURIEUX, DIDIER PÉLAPRAT, JEAN MARIE ZAJAC, MARIE-CLAUDE FOURNIÉ-ZALUSKI, GILLES GACEL and BERNARD P. ROQUES

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29959.x

    8. Forebrain Projections from Midbrain Cholecystokinin-containing Neurons in the Rat (pages 596–597)

      JAMES H. FALLON and KIM B. SEROOGY

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29960.x

    9. Conformational Analysis and Structural Activity Relationships of Cholecystokinin Peptides (pages 598–600)

      M-C. FOURNIÉ-ZALUSKI, J. BELLENEY, C. DURIEUX, G. GACEL, B. P. ROQUES, D. BÉGUÉ, I. MENANT, B. LUX and D. GÉRARD

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29961.x

    10. Depolarization-evoked Release of Endogenous Dopamine and Cholecystokinin from Rat Striatal Slices (pages 607–608)

      J. B. HUTCHISON, S. R. NAHORSKI and J. STRUPISH

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29964.x

    11. Molecular Cloning of the Human Cholecystokinin Gene (pages 613–615)

      KIKUYA KATO, YOOSUKE TAKAHASHI and KENICHI MATSUBARA

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29966.x

    12. The Pyloric Cholecystokinin Receptor A Site of Mediation for Satiety? (pages 621–623)

      TIMOTHY H. MORAN, PAUL H. ROBINSON and PAUL R. McHUGH

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29968.x

    13. Autoradiographic Localization of Cholecystokinin Receptors in Human Brain (pages 624–626)

      RÉMI QUIRION, CATHERINE CSONKA, PIERRE ETIENNE, N. P. V. NAIR, YVES ROBITAILLE and PIERRETTE GAUDREAU

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29969.x

    14. Effects of Proglumide on Morphine Analgesia and Tolerance (pages 630–632)

      LUCIO C. ROVATI, PAOLA SACERDOTE and ALBERTO E. PANERAI

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29971.x

    15. The Effects of Cholecystokinin Octapeptide and Proglumide on Electrically Elicited Eating (pages 633–635)

      LINDA H. SCHNEIDER, JOEL M. KAPLAN, SAMUEL M. FELDMAN, EDGAR E. COONS and RANDALL B. MURPHY

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29972.x

    16. Cholecystokinin Innervation of Rat Cerebral Cortex (pages 636–639)

      KIM B. SEROOGY and JAMES H. FALLON

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29973.x

    17. Cholecystokinin Octapeptide Action on Gastric Emptying and Food Intake in Normal and Vagotomized Man (pages 640–641)

      M. J. SHAW, J. J. HUGHES, J. E. MORLEY, A. S. LEVINE, S. E. SILVIS and R. B. SHAFER

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29974.x

    18. Naloxone Potentiation of the Antinociceptive Action of Caerulein (pages 642–647)

      M. J. SHEEHAN and J. DE BELLEROCHE

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29975.x

    19. Cholecystokinin in Discrete Rat Brain Regions as a Function of Sex and Estrous Cycle (pages 651–653)

      R. A. SIEGEL, M. FRANKFURT, U. PAHNKE and W. WUTTKE

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29977.x

    20. The Potentiation of Morphine-induced Inhibition of Spinal Transmission by Proglumide, a Putative Cholecystokinin Antagonist (pages 660–662)

      S. N. SUBERG, E. S. CULHANE, E. CARSTENS and L. R. WATKINS

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29980.x

    21. Cholecystokinin Octapeptide's Effect on Local Cerebral Glucose Utilization in the Laboratory Rat (pages 663–665)

      C. A. TAMMINGA, G. LUCIGNANI, L. J. PORRINO and T. N. CHASE

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29981.x

    22. Metabolism of Cholecystokinin by Endopeptidase-24.11 (pages 666–668)

      ANTHONY J. TURNER, REBECCA MATSAS and A. JOHN KENNY

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29982.x

    23. Neuroleptic-like Activity and Antipsychotic Action of Cholecystokinin-related Peptides (pages 671–673)

      JAN M. VAN REE and DAVID DE WIED

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29984.x

    24. Effects of Cholecystokinin on Dopamine Release in the Nucleus Accumbens (pages 674–675)

      MARK M. VOIGT, REX Y. WANG and THOMAS C. WESTFALL

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29985.x

    25. The Enhancement of Opiate Analgesia and the Possible Reversal of Morphine Tolerance by Proglumide (pages 676–677)

      L. R. WATKINS, I. B. KINSCHECK, G. ROSENQUIST, J. MILLER, S. WIMBERG, H. FRENK, E. KAUFMAN, R. COGHILL, S. N. SUBERG and D. J. MAYER

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29986.x

    26. Characterization of Cholecystokinin Recognition Sites in Mouse Cerebral Cortex Using a Radiolabeled Octapeptide (pages 678–681)

      LAWRENCE WENNOGLE, DOUGLAS STEEL and BARBARA PETRACK

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29987.x

    27. Effects of Chronic Treatment with Cholecystokinin on Midbrain Dopamine Neurons (pages 682–684)

      FRANCIS J. WHITE and REX Y. WANG

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29988.x

    28. Assessment of the Role of “Enkephalinase” in Cholecystokinin Inactivation (pages 685–686)

      KATHERINE A. ZUZEL, CHRISTIANE ROSE and JEAN-CHARLES SCHWARTZ

      Version of Record online: 16 DEC 2006 | DOI: 10.1111/j.1749-6632.1985.tb29989.x

SEARCH

SEARCH BY CITATION